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ABSTRACT 
Studies demonstrated that mesenchymal stromal cells (MSC) from bone marrow stroma 
produced high concentration of interleukin-6 (IL-6) that promoted multiple myeloma cell 
growth. In view of the failure of IL-6 monoclonal antibody therapy to demonstrate substantial 
clinical responses in early clinical trials, more effective methods are needed in order to 
disrupt the favourable microenvironment provided by the bone marrow stroma. In this study, 
we evaluated the short interfering RNA (siRNA)-mediated silencing of IL-6 in MSC and the 
efficacy of these genetically modified MSC, with IL-6 suppression, on inhibition of U266 
multiple myeloma cell growth. IL-6 mRNA and protein were significantly suppressed by 72 h 
post IL-6 siRNA transfection without affecting the biological properties of MSC. Here we 
show significant inhibition of cell growth and IL-6 production in U266 cells co-cultured with 
MSC transfected with IL-6 siRNA when compared to U266 cells co-cultured with control 
MSC. We also show that the tumour volume and mitotic index of tumours in nude mice co-
injected with U266 and MSC transfected with IL-6 siRNA were significantly reduced 
compared to tumours of mice co-injected with control MSC. Our results suggest potential use 
of RNA interference mediated therapy for multiple myeloma. 
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